Think Gene - Latest Comments in Study validates Pittsburgh Compound-B in identifying Alzheimer’s disease brain toxin

Re: Study validates Pittsburgh Compound-B in identifying Alzheimer’s disease brain toxin

Life in Italy — Tue, 16 Feb 2010 12:27:10 -0000

It is estimated that up to 4.5 million people in the United States have Alzheimer’s.

Re: Study validates Pittsburgh Compound-B in identifying Alzheimer’s disease brain toxin

Pariuri Sportive — Thu, 11 Feb 2010 02:28:26 -0000

well worth the read.I found it very informative as I have been researching a lot lately on practical matters such as you talk about...

Re: Study validates Pittsburgh Compound-B in identifying Alzheimer’s disease brain toxin

Djarum Black — Tue, 09 Feb 2010 13:03:28 -0000

A groundbreaking study conducted by University of Pittsburgh Alzheimer’s disease researchers reported in the journal Brain (currently online) confirms that Pittsburgh Compound-B (PiB) binds to the telltale beta-amyloid deposits found in the brains of patients with Alzheimer’s disease. The finding is a significant step toward enabling clinicians to provide a definitive diagnosis of Alzheimer’s disease in living patients

Re: Study validates Pittsburgh Compound-B in identifying Alzheimer’s disease brain toxin

Gunz Hacks — Sun, 24 Jan 2010 09:06:47 -0000

The new findings, which correlate PiB-identified beta-amyloid deposits from living patients to their post-mortem autopsy results, will ultimately aid in the early diagnosis of Alzheimer’s, help clinicians monitor the progression of the disease and further the development of potential treatments.

Re: Study validates Pittsburgh Compound-B in identifying Alzheimer’s disease brain toxin

Free Online Games — Fri, 22 Jan 2010 11:48:56 -0000

Invented and developed by Pitt researchers Chester Mathis, Ph.D., professor of radiology and pharmaceutical sciences, and William Klunk, M.D., Ph.D., professor of psychiatry and neurology, PiB is a radioactive compound that, when coupled with positron emission tomography (PET) imaging, can be injected into the bloodstream to enable researchers to visualize the brains of people with the memory-stealing illness and see the location and distribution of the beta-amyloid plaque deposits associated with Alzheimer’s.

Re: Study validates Pittsburgh Compound-B in identifying Alzheimer’s disease brain toxin

Buy Finpecia Online — Wed, 13 Jan 2010 14:33:13 -0000

The findings from our study of her brain, coupled with the further confirmation of the other 27 brains, tell us without a doubt that PiB binds to beta-amyloid and that it is a reliable indicator of the presence of Alzheimer’s disease in those who are suffering its cruel effects,” said Dr. Klunk.